700,000 Seniors Start Weight Loss Drugs Under Medicare

More than half a million seniors are finally getting help with weight loss thanks to a Medicare program that launched last summer.

Eli Lilly CEO Dave Ricks shared encouraging numbers on Monday: 700,000 new patients over age 65 have started GLP-1 treatments since Medicare began covering obesity drugs in July. That's a huge leap forward for seniors who've struggled with weight-related health issues but couldn't afford the medications.

The coverage comes through a temporary program called Bridge, which lets eligible Medicare beneficiaries get weight loss drugs for just $50 a month. Before this program, these same medications could cost patients over $1,000 monthly out of pocket.

Medicare serves about 66 million Americans who are 65 and older or have disabilities. Now thousands of them can access treatments like Zepbound injections and newer pill options that help people lose significant weight and improve conditions like diabetes and heart disease.

Ricks called the rollout "very encouraging" and praised how smoothly the program has worked. Doctors are focusing on patients with the most weight to lose and serious health complications first, which means the coverage is reaching people who need it most.

The newer pill options are also opening doors for patients who prefer convenience. About one-third of seniors choosing oral medications are picking Foundayo, a pill launched in April that works well for people looking to lose 25 to 30 pounds.

The Ripple Effect

This Medicare coverage represents more than just weight loss. It's giving seniors a real shot at healthier aging with fewer complications from obesity-related diseases.

The program shows what's possible when life-changing medications become accessible. Seniors who've spent years struggling with weight now have affordable options that can improve their mobility, reduce their risk of heart disease and diabetes, and boost their overall quality of life.

The Centers for Medicare and Medicaid Services worked closely with drug companies and insurance providers to make the rollout smooth, with few logistical hiccups reported. That coordination meant seniors could actually access their prescriptions without drowning in red tape.

Seven hundred thousand people getting treatment in just eight months proves there was massive unmet need. These aren't just statistics. They're grandparents gaining energy to play with grandkids, retirees reclaiming active lifestyles, and people finally getting tools that work after decades of struggle.

The Bridge program is temporary for now, but its early success could pave the way for permanent Medicare coverage that helps millions more Americans achieve healthier lives.